Matches in Wikidata for { <http://www.wikidata.org/entity/Q58159480> ?p ?o ?g. }
Showing items 1 to 71 of
71
with 100 items per page.
- Q58159480 description "im März 2001 veröffentlichter wissenschaftlicher Artikel" @default.
- Q58159480 description "journal article; published in Acute Cardiac Care in 2001" @default.
- Q58159480 description "journal article; published in Acute Cardiac Care in 2001" @default.
- Q58159480 description "journal article; published in Acute Cardiac Care in 2001" @default.
- Q58159480 description "wetenschappelijk artikel" @default.
- Q58159480 description "наукова стаття, опублікована в січні 2001" @default.
- Q58159480 name "Selective use of abciximab in coronary stenting: overall outcomes can still be equivalent to those in the EPISTENT treatment group" @default.
- Q58159480 name "Selective use of abciximab in coronary stenting: overall outcomes can still be equivalent to those in the EPISTENT treatment group" @default.
- Q58159480 name "Selective use of abciximab in coronary stenting: overall outcomes can still be equivalent to those in the EPISTENT treatment group" @default.
- Q58159480 name "Selective use of abciximab in coronary stenting: overall outcomes can still be equivalent to those in the EPISTENT treatment group" @default.
- Q58159480 type Item @default.
- Q58159480 label "Selective use of abciximab in coronary stenting: overall outcomes can still be equivalent to those in the EPISTENT treatment group" @default.
- Q58159480 label "Selective use of abciximab in coronary stenting: overall outcomes can still be equivalent to those in the EPISTENT treatment group" @default.
- Q58159480 label "Selective use of abciximab in coronary stenting: overall outcomes can still be equivalent to those in the EPISTENT treatment group" @default.
- Q58159480 label "Selective use of abciximab in coronary stenting: overall outcomes can still be equivalent to those in the EPISTENT treatment group" @default.
- Q58159480 prefLabel "Selective use of abciximab in coronary stenting: overall outcomes can still be equivalent to those in the EPISTENT treatment group" @default.
- Q58159480 prefLabel "Selective use of abciximab in coronary stenting: overall outcomes can still be equivalent to those in the EPISTENT treatment group" @default.
- Q58159480 prefLabel "Selective use of abciximab in coronary stenting: overall outcomes can still be equivalent to those in the EPISTENT treatment group" @default.
- Q58159480 prefLabel "Selective use of abciximab in coronary stenting: overall outcomes can still be equivalent to those in the EPISTENT treatment group" @default.
- Q58159480 P1433 Q58159480-7BA81768-1045-4978-850B-7FF2DE94EDF3 @default.
- Q58159480 P1476 Q58159480-E36EF524-3743-4AD3-A24C-E13BC820A79B @default.
- Q58159480 P2093 Q58159480-3BB669B9-78FB-4F70-A598-BFCAB78950AD @default.
- Q58159480 P2093 Q58159480-72A0BFFF-028B-46F6-8EBC-B57A7CD403C4 @default.
- Q58159480 P2093 Q58159480-788A3927-56CF-4653-B520-BC4B6623E301 @default.
- Q58159480 P2093 Q58159480-95836D3B-9284-4597-9E72-E354D54F9007 @default.
- Q58159480 P2093 Q58159480-CA776CE0-0498-4555-B5EF-EF4A4870C30D @default.
- Q58159480 P2093 Q58159480-E8F11A3D-A4D8-48A2-932A-81F1D6A2F3DC @default.
- Q58159480 P2860 Q58159480-1E076945-D829-49A3-BA05-D4E38FA190B6 @default.
- Q58159480 P2860 Q58159480-3CB46FC9-FEBC-4812-AC54-A1B96ACCE34F @default.
- Q58159480 P2860 Q58159480-54F79C73-37D8-4257-B1EF-1EB11213F06D @default.
- Q58159480 P2860 Q58159480-57DF7BAB-88FE-4E07-BBF0-07685521A374 @default.
- Q58159480 P2860 Q58159480-9ADF58F7-265F-48A6-B07C-C19F26BD93D1 @default.
- Q58159480 P2860 Q58159480-B15B74B2-45EA-41C5-AFD9-6E2397981A77 @default.
- Q58159480 P2860 Q58159480-C759F59C-76B9-4851-8FA8-579ABDDEDE59 @default.
- Q58159480 P2860 Q58159480-CED12E02-F478-4C7D-8FD0-BABB384773E3 @default.
- Q58159480 P304 Q58159480-7A8DE6F2-A3D5-4E01-9BAB-C8F2E036056A @default.
- Q58159480 P31 Q58159480-4747624C-41E0-40C6-9AEF-4FB401E4B1C7 @default.
- Q58159480 P356 Q58159480-92D20CF0-2885-498A-BA47-551777E2195B @default.
- Q58159480 P433 Q58159480-786B50C7-FAA3-456A-AD7C-3710DDD6C8E5 @default.
- Q58159480 P478 Q58159480-382FE64B-2C99-4E8C-97BE-3B56AA43FBA0 @default.
- Q58159480 P50 Q58159480-B67F301E-5330-4BA6-AFE2-248048EDF319 @default.
- Q58159480 P577 Q58159480-45435394-FF70-4D71-9312-64B06CEA8501 @default.
- Q58159480 P698 Q58159480-7C315FE7-5E04-4A43-A52B-2DDBD13C4750 @default.
- Q58159480 P856 Q58159480-1938DC5D-D40E-4D13-9248-0DCE99131F4F @default.
- Q58159480 P356 146288401316922643 @default.
- Q58159480 P698 12431335 @default.
- Q58159480 P1433 Q27719162 @default.
- Q58159480 P1476 "Selective use of abciximab in coronary stenting: overall outcomes can still be equivalent to those in the EPISTENT treatment group" @default.
- Q58159480 P2093 "A Davies" @default.
- Q58159480 P2093 "A GC Sutton" @default.
- Q58159480 P2093 "D JA Price" @default.
- Q58159480 P2093 "E D Grech" @default.
- Q58159480 P2093 "M A De Belder" @default.
- Q58159480 P2093 "P G Campbell" @default.
- Q58159480 P2860 Q33504515 @default.
- Q58159480 P2860 Q34336722 @default.
- Q58159480 P2860 Q34374902 @default.
- Q58159480 P2860 Q37694288 @default.
- Q58159480 P2860 Q39486711 @default.
- Q58159480 P2860 Q47808971 @default.
- Q58159480 P2860 Q56944919 @default.
- Q58159480 P2860 Q56945137 @default.
- Q58159480 P304 "15-20" @default.
- Q58159480 P31 Q13442814 @default.
- Q58159480 P356 "10.1080/146288401316922643" @default.
- Q58159480 P433 "1" @default.
- Q58159480 P478 "4" @default.
- Q58159480 P50 Q44359561 @default.
- Q58159480 P577 "2001-03-01T00:00:00Z" @default.
- Q58159480 P698 "12431335" @default.
- Q58159480 P856 146288401316922643 @default.